What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?

Background: The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service. This assumption is based on a theoretical calculation. This study aimed to find out the actual pr...

Full description

Bibliographic Details
Main Authors: Wells, Katharine M., Boyd, Matthew J., Thornley, Tracey, Boardman, Helen F.
Format: Article
Published: BIOMED 2014
Online Access:https://eprints.nottingham.ac.uk/49250/
_version_ 1848797956647419904
author Wells, Katharine M.
Boyd, Matthew J.
Thornley, Tracey
Boardman, Helen F.
author_facet Wells, Katharine M.
Boyd, Matthew J.
Thornley, Tracey
Boardman, Helen F.
author_sort Wells, Katharine M.
building Nottingham Research Data Repository
collection Online Access
description Background: The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service. This assumption is based on a theoretical calculation. This study aimed to find out the actual proportion of prescription items eligible for the NMS dispensed in community pharmacies in order to compare this with the theoretical assumption. The study also aimed to investigate whether the proportion of prescription items eligible for the NMS is affected by pharmacies’ proximity to GP practices. Methods: The study collected data from eight pharmacies in Nottingham belonging to the same large chain of pharmacies. Pharmacies were grouped by distance from the nearest GP practice and sampled to reflect the distribution by distance of all pharmacies in Nottingham. Data on one thousand consecutive prescription items were collected from each pharmacy and the number of NMS eligible items recorded. All NHS prescriptions were included in the sample. Data were analysed and proportions calculated with 95% confidence intervals used to compare the study results against the theoretical figure of 0.5% of prescription items being eligible for the NMS. Results: A total of 8005 prescription items were collected (a minimum of 1000 items per pharmacy) of which 17 items were eligible to receive the service. The study found that 0.25% (95% confidence intervals: 0.14% to 0.36%) of prescription items were eligible for the NMS which differs significantly from the theoretical assumption of 0.5%. The opportunity rate for the service was lower, 0.21% (95% confidence intervals: 0.10% to 0.32%) of items, as some items eligible for the NMS did not translate into opportunities to offer the service. Of all the prescription items collected in the pharmacies, 28% were collected by patient representatives. Conclusions: The results of this study show that the proportion of items eligible for the NMS dispensed in community pharmacies is lower than the Department of Health assumption of 0.5%. This study did not find a significant difference in the rate of NMS opportunities between pharmacies located close to GP practices compared to those further away.
first_indexed 2025-11-14T20:12:07Z
format Article
id nottingham-49250
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:12:07Z
publishDate 2014
publisher BIOMED
recordtype eprints
repository_type Digital Repository
spelling nottingham-492502020-05-04T16:45:15Z https://eprints.nottingham.ac.uk/49250/ What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service? Wells, Katharine M. Boyd, Matthew J. Thornley, Tracey Boardman, Helen F. Background: The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service. This assumption is based on a theoretical calculation. This study aimed to find out the actual proportion of prescription items eligible for the NMS dispensed in community pharmacies in order to compare this with the theoretical assumption. The study also aimed to investigate whether the proportion of prescription items eligible for the NMS is affected by pharmacies’ proximity to GP practices. Methods: The study collected data from eight pharmacies in Nottingham belonging to the same large chain of pharmacies. Pharmacies were grouped by distance from the nearest GP practice and sampled to reflect the distribution by distance of all pharmacies in Nottingham. Data on one thousand consecutive prescription items were collected from each pharmacy and the number of NMS eligible items recorded. All NHS prescriptions were included in the sample. Data were analysed and proportions calculated with 95% confidence intervals used to compare the study results against the theoretical figure of 0.5% of prescription items being eligible for the NMS. Results: A total of 8005 prescription items were collected (a minimum of 1000 items per pharmacy) of which 17 items were eligible to receive the service. The study found that 0.25% (95% confidence intervals: 0.14% to 0.36%) of prescription items were eligible for the NMS which differs significantly from the theoretical assumption of 0.5%. The opportunity rate for the service was lower, 0.21% (95% confidence intervals: 0.10% to 0.32%) of items, as some items eligible for the NMS did not translate into opportunities to offer the service. Of all the prescription items collected in the pharmacies, 28% were collected by patient representatives. Conclusions: The results of this study show that the proportion of items eligible for the NMS dispensed in community pharmacies is lower than the Department of Health assumption of 0.5%. This study did not find a significant difference in the rate of NMS opportunities between pharmacies located close to GP practices compared to those further away. BIOMED 2014-03-07 Article PeerReviewed Wells, Katharine M., Boyd, Matthew J., Thornley, Tracey and Boardman, Helen F. (2014) What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service? BMC Health Services Research, 14 (1). p. 115. ISSN 1472-6963 https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-115 doi:10.1186/1472-6963-14-115 doi:10.1186/1472-6963-14-115
spellingShingle Wells, Katharine M.
Boyd, Matthew J.
Thornley, Tracey
Boardman, Helen F.
What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title_full What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title_fullStr What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title_full_unstemmed What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title_short What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
title_sort what proportion of prescription items dispensed in community pharmacies are eligible for the new medicine service?
url https://eprints.nottingham.ac.uk/49250/
https://eprints.nottingham.ac.uk/49250/
https://eprints.nottingham.ac.uk/49250/